Back
Summit Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
SMMT
Summit Therapeutics
Last Price:
$27.62
Seasonality Move:
9.76%
7 Day Trial
ALL ACCESS PASS
$
7
Summit Therapeutics Stock Forecast
-
Over the next 52 weeks, Summit Therapeutics has on average historically risen by 71.4% based on the past 10 years of stock performance.
-
Summit Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Summit Therapeutics Stock Undervalued?The current Summit Therapeutics [SMMT] share price is $28.27. The Score for SMMT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Summit Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Summit Therapeutics has on average historically risen by 71.4% based on the past 10 years of stock performance.
Summit Therapeutics Stock Rating
Buy
61
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics overpriced?
-
Summit Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Summit Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com
52-Week Data
52-Week High:
36.91
52-Week Low:
8.71
Prediction Charts
Market Cap:
21B
Price in USD:
28.27
Volume:
6.1M
Beta:
-0.23
Technical Analysis
SMA50:
22.83
SMA100:
22.17
SMA200:
21.01
52-Wk Change:
209.98%
Stock Predictions
-
Is Summit Therapeutics stock public?Yes, Summit Therapeutics is a publicly traded company.
-
What is the Summit Therapeutics stock quote today?The Summit Therapeutics stock price is 28.27 USD today.
-
How to buy Summit Therapeutics stock online?You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-26 | 21.24 | 21.32 | 21.65 | 21.01 |
| Jun-27 | 21.25 | 20.60 | 21.35 | 20.27 |
| Jun-30 | 20.79 | 21.28 | 21.31 | 20.33 |
| Jul-1 | 21.28 | 21.20 | 21.76 | 20.62 |
| Jul-2 | 21.24 | 22.62 | 22.84 | 21.17 |
| Jul-3 | 23.00 | 24.55 | 25.94 | 20.49 |
| Jul-7 | 23.60 | 22.61 | 23.69 | 22.40 |
| Jul-8 | 22.70 | 22.99 | 23.02 | 22.16 |
| Jul-9 | 23.40 | 24.74 | 25.05 | 23.23 |
| Jul-10 | 24.88 | 25.88 | 26.33 | 24.27 |
| Jul-11 | 25.52 | 25.00 | 25.72 | 24.76 |
| Jul-14 | 25.10 | 25.40 | 25.61 | 24.63 |
| Jul-15 | 25.38 | 24.36 | 25.55 | 24.09 |
| Jul-16 | 25.00 | 28.27 | 28.62 | 25.00 |
Summit Therapeutics Earnings
Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Summit Therapeutics Forecast Revenue Growth
Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.